Pharmaceutical - USA

Filter

Current filters:

USA

Popular Filters

1 to 25 of 549 results

Johnson & Johnson to acquire Alios BioPharma

Johnson & Johnson to acquire Alios BioPharma

30-09-2014

US health care giant Johnson & Johnson has signed a definitive agreement to acquire Alios BioPharma,…

AL-8176Alios BioPharmaAnti-viralsJohnson & JohnsonMergers & AcquisitionsPharmaceuticalUSA

Bristol-Myers Squibb updates on Opdivo regulatory milestones

30-09-2014

US pharma major Bristol-Myers Squibb has announced multiple regulatory milestones for Opdivo (nivolumab),…

Bristol-Myers SquibbEuropeOncologyOno PharmaceuticalOpdivoPharmaceuticalRegulationUSA

Canada and Europe sometimes years slower than USA in approving cancer

29-09-2014

Access to potentially life-extending cancer drugs varies significantly in different regions of the world,…

CanadaEastern EuropeEuropeOncologyPharmaceuticalRegulationUSA

US FDA approves Iluvien for diabetic macular edema

US FDA approves Iluvien for diabetic macular edema

28-09-2014

US ophthalmic drug specialist Alimera Sciences says that the US Food and Drug Administration has approved…

Alimera SciencesIluvienMedidurOphthalmicsPharmaceuticalpSividaRegulationTethadurUSA

Novo Nordisk establishes new obesity research unit in Seattle

Novo Nordisk establishes new obesity research unit in Seattle

26-09-2014

Danish diabetes care giant Novo Nordisk yesterday announced that the company will establish a new obesity…

ManagementMetabolicsNovo NordiskPharmaceuticalResearchSaxendaUSA

Top 100 US drug pricing average jumps seven-fold to $9,400 in 2014

Top 100 US drug pricing average jumps seven-fold to $9,400 in 2014

26-09-2014

The median price of the top 100 drugs has skyrocketed from $1,260 in 2010 to $9,400 in 2014, representing…

PharmaceuticalPharmacologyPricingUnited StatesUSA

Boehringer’s Spiriva Respimat OKed by FDA for maintenance treatment of COPD

Boehringer’s Spiriva Respimat OKed by FDA for maintenance treatment of COPD

25-09-2014

German family-owned pharma major Boehringer Ingelheim Pharmaceuticals has received US Food and Drug Administration…

Boehringer IngelheimPharmaceuticalRegulationRespiratory and PulmonarySpirivaUSA

AbbVie's Humira gains added indication from US FDA

AbbVie's Humira gains added indication from US FDA

25-09-2014

The US Food and Drug Administration has approved US drugmaker AbbVie’s Humira (adalimumab) for reducing…

AbbVieGastro-intestinalsHumiraInflammatory diseasesPharmaceuticalRegulationUSA

FDA warning letters rise 78% over six years with increase expected in 2015

FDA warning letters rise 78% over six years with increase expected in 2015

25-09-2014

The number of warning letters sent by the US Food and Drug Administration increased substantially by…

PharmaceuticalRegulationUSA

Shire to pay $56.5 million in final agreement with US government

Shire to pay $56.5 million in final agreement with US government

25-09-2014

The US subsidiary of Ireland-headquartered Shire will pay $56.5 million to resolve civil allegations…

AbbVieAdderallFinancialLegalPharmaceuticalShireUSAVyvanse

OPKO's second Rayaldee Ph III trial meets primary endpoints

OPKO's second Rayaldee Ph III trial meets primary endpoints

24-09-2014

US drugmaker OPKO Health has released successful top-line results from the second and final pivotal Phase…

Nephrology and HepatologyOPKO HealthPharmaceuticalRayaldeeResearchUSA

FDA accepts NDA filing for Lundbeck and Otsuka's brexpiprazole

FDA accepts NDA filing for Lundbeck and Otsuka's brexpiprazole

24-09-2014

The US Food and Drug Administration has accepted the filing for review of brexiprazole for the treatment…

CNS DiseasesLundbeckOtsukaPharmaceuticalRegulationUSA

Statins can lead to increased survival after hemorrhagic stroke, study finds

Statins can lead to increased survival after hemorrhagic stroke, study finds

24-09-2014

Patients who were treated with a statin in hospital after suffering from a hemorrhagic stroke were significantly…

Cardio-vascularHealthHemorrhagic strokePharmaceuticalResearchStatinStrokeUSA

Actavis approached by Pfizer in latest takeover deal, according to sources

Actavis approached by Pfizer in latest takeover deal, according to sources

24-09-2014

US pharma giant Pfizer has held talks regarding an acquisition of Ireland-headquartered generics major…

ActavisMergers & AcquisitionsPfizerPharmaceuticalUSA

Decline in sales rep access makes digital communications vital, says ZS report

Decline in sales rep access makes digital communications vital, says ZS report

24-09-2014

Digital communication channels are becoming increasingly important as cost pressures mean drug reps reduce…

BusinessMarkets & MarketingPharmaceuticalResearchUnited StatesUSA

NovaDel sells ZolpiMist NDA, license and IP to Amherst Pharma

23-09-2014

NovaDel Pharma has sold its insomnia drug ZolpiMist (zolpidem oral spray) New Drug Application to fellow…

Amherst PharmaceuticalsMergers & AcquisitionsNeurologicalNovaDel PharmaPharmaceuticalUSAZolpiMist

US Treasury to crack down on tax inversion M&A deals

US Treasury to crack down on tax inversion M&A deals

23-09-2014

The USA’s Department of the Treasury announced on Monday that it is taking action to reduce the tax…

FinancialMergers & AcquisitionsPharmaceuticalPoliticsUSA

Auxilium Pharma rejects Endo acquisition in favor of QLT deal

Auxilium Pharma rejects Endo acquisition in favor of QLT deal

22-09-2014

Auxilium Pharmaceuticals’ board of directors, after review of the unsolicited $2.2 billion takeover…

AuxiliumCanadaEndo InternationalMen's HealthMergers & AcquisitionsPharmaceuticalQLTUSA

Skyepharma will repay 12.7 million euros ahead of Exparel milestone

Skyepharma will repay 12.7 million euros ahead of Exparel milestone

22-09-2014

UK-based Skyepharma, an oral and inhalation drug delivery company, has given notice to CRC European Loan…

AnalgesiaExparelFinancialPacira PharmaceuticalsPharmaceuticalSkyepharmaUKUSA

1 to 25 of 549 results

Back to top